Cargando…
Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084092/ https://www.ncbi.nlm.nih.gov/pubmed/36722017 http://dx.doi.org/10.1093/ehjcvp/pvad011 |
| _version_ | 1785021663141691392 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10084092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100840922023-04-11 Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis Eur Heart J Cardiovasc Pharmacother Corrigendum Oxford University Press 2023-01-31 /pmc/articles/PMC10084092/ /pubmed/36722017 http://dx.doi.org/10.1093/ehjcvp/pvad011 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigendum Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis |
| title | Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis |
| title_full | Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis |
| title_fullStr | Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis |
| title_full_unstemmed | Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis |
| title_short | Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis |
| title_sort | corrigendum to: association between use of novel glucose-lowering drugs and covid-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084092/ https://www.ncbi.nlm.nih.gov/pubmed/36722017 http://dx.doi.org/10.1093/ehjcvp/pvad011 |